Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Testosterone topical - AbbVie/Besins/Mylan

Drug Profile

Testosterone topical - AbbVie/Besins/Mylan

Alternative Names: 1% Testosterone gel (AndroGel) - AbbVie; 1.62% Testosterone gel - Solvay; AndroGel; AndroGel PD; Testogel; Testosterone topical - Abbott

Latest Information Update: 04 Nov 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Besins International; Unimed Pharmaceuticals
  • Developer AbbVie; Besins Healthcare; Solvay
  • Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Androgen receptor agonists; Growth stimulants; Testosterone congener stimulants; Testosterone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Hypogonadism
  • Discontinued Growth disorders

Most Recent Events

  • 07 Aug 2018 Solvay Pharmaceuticals completes a phase I trial in Hypogonadism in USA (Topical) (NCT00425568)
  • 04 Feb 2016 No recent reports on development identified - Phase-III for Hypogonadism in China (Topical)
  • 02 Sep 2015 First Generic equivalent available in USA for Hypogonadism
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top